Hainan Haishen Tongzhou Pharmaceutical Co., Ltd.
-
Founded in:
1993-08-03 -
Country:
China -
Address:
No. 6, Yaogu 2nd Road, Yaogu Industrial Park, National High-tech Zone, Haikou City, Hainan Province -
Tax NO.:
91460100283995932K -
Registered Funds:
10.5 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clarithromycin |
This product is a macrolide antibiotic, which has inhibitory effects on Gram-positive bacteria such as Staphylococcus aureus, Streptococcus, and Pneumococcus, as well as some Gram-negative bacteria such as Haemophilus influenzae, Bordetella pertussis, Neisseria gonorrhoeae, Legionella pneumophila, and some anaerobic bacteria such as Bacteroides fragilis, Streptococcus peptostreptococcus, and Propionibacterium acnes. In addition, it also has inhibitory effects on mycoplasma. The characteristics of this product are that its antibacterial activity in vitro is similar to that of erythromycin, but its antibacterial activity in vivo against some bacteria such as Staphylococcus aureus, Streptococcus, and Haemophilus influenzae is stronger than that of erythromycin. There is cross-resistance between this product and erythromycin. The mechanism of action of this product is to inhibit the association of the 50S subunit of the nuclear protein and inhibit protein synthesis to produce an antibacterial effect.
More
This product is a macrolide antibiotic, which has inhibitory effects on Gram-positive bacteria such as Staphylococcus aureus, Streptococcus, and Pneumococcus, as well as some Gram-negative bacteria such as Haemophilus influenzae, Bordetella pertussis, Neisseria gonorrhoeae, Legionella pneumophila, and some anaerobic bacteria such as Bacteroides fragilis, Streptococcus peptostreptococcus, and Propionibacterium acnes. In addition, it also has inhibitory effects on mycoplasma. The characteristics of this product are that its antibacterial activity in vitro is similar to that of erythromycin, but its antibacterial activity in vivo against some bacteria such as Staphylococcus aureus, Streptococcus, and Haemophilus influenzae is stronger than that of erythromycin. There is cross-resistance between this product and erythromycin. The mechanism of action of this product is to inhibit the association of the 50S subunit of the nuclear protein and inhibit protein synthesis to produce an antibacterial effect. |
81103-11-9 | 46 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Phellodendri Chinensis Cortex |
Antibacterial, antiviral, antipyretic and anti-inflammatory
More
Antibacterial, antiviral, antipyretic and anti-inflammatory |
0 | ||
| Chrysophanic acid |
Antibacterial, antiviral, antipyretic and anti-inflammatory
More
Antibacterial, antiviral, antipyretic and anti-inflammatory |
481-74-3 | 0 | |
| RADIX SCUTELLARIAE |
Antibacterial, antiviral, antipyretic and anti-inflammatory
More
Antibacterial, antiviral, antipyretic and anti-inflammatory |
0 | ||
| Isatidis Radix |
Antibacterial, antiviral, antipyretic and anti-inflammatory
More
Antibacterial, antiviral, antipyretic and anti-inflammatory |
0 | ||
| COPTIDISRHIZOMA |
Antibacterial, antiviral, antipyretic and anti-inflammatory
More
Antibacterial, antiviral, antipyretic and anti-inflammatory |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ketoconazole |
Ketoconazole is an antifungal drug that has inhibitory effects on dermatophytes such as Trichophyton, Epidermophyton, Microsporum, and yeasts such as Candida. It is hardly absorbed through the skin when applied topically.
More
Ketoconazole is an antifungal drug that has inhibitory effects on dermatophytes such as Trichophyton, Epidermophyton, Microsporum, and yeasts such as Candida. It is hardly absorbed through the skin when applied topically. |
65277-42-1 | 25 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Zolmitriptan |
Selective 5-HTIB/ID receptor agonist. It stimulates the 5-HTIB/ID receptors on intracranial blood vessels and sympathetic nerves of the trigeminal nervous system, causing intracranial vasoconstriction and inhibiting the release of pro-inflammatory neuropeptides. It is used to treat migraine with or without aura in adults.
More
Selective 5-HTIB/ID receptor agonist. It stimulates the 5-HTIB/ID receptors on intracranial blood vessels and sympathetic nerves of the trigeminal nervous system, causing intracranial vasoconstriction and inhibiting the release of pro-inflammatory neuropeptides. It is used to treat migraine with or without aura in adults. |
139264-17-8 | 37 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Zolmitriptan |
Zolmitriptan is a selective 5-HTIB/ID receptor agonist. It stimulates 5-HTIB/ID receptors on intracranial blood vessels (including arteriovenous anastomosis) and sympathetic nerves of the trigeminal nervous system, causing intracranial vasoconstriction and inhibiting the release of pro-inflammatory neuropeptides. It is used to treat migraine with or without aura in adults.
More
Zolmitriptan is a selective 5-HTIB/ID receptor agonist. It stimulates 5-HTIB/ID receptors on intracranial blood vessels (including arteriovenous anastomosis) and sympathetic nerves of the trigeminal nervous system, causing intracranial vasoconstriction and inhibiting the release of pro-inflammatory neuropeptides. It is used to treat migraine with or without aura in adults. |
139264-17-8 | 37 |